According to the Low Dose Naltrexone home page [LDN], LDN has been seen to benefit
Behçet's Disease, which is considered to be an autoimmune disease.
[LDN] reports that all patients with autoimmune processes whom the late
Dr. Bihari [Bihari2003] treated using LDN "have experienced a halt in progression of
their illness.
In many patients there was a marked remission in signs and symptoms of the disease."
Dr. Bihari suggests a 50% to 70% overall response rate [Bihari2003].
Please see [LDN_Denise] for a video interview of a patient with Behçet's disease who
has benefitted from LDN.
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN).
However, Dr. Weyrich has not treated any cases of Behçet's Disease with LDN.
Please see What is Low Dose Naltrexone?
for more information.